Effectiveness of Laser treatment in Glaucoma

Effectiveness of selective laser trabeculoplasty (SLT) vs topical anti glaucoma medications in early primary open angle glaucoma and ocular hypertension (OHT) as first line treatment - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076951

Enrollment

Registered

2024-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: Selective Laser Trabeculoplasty (SLT) and topical anti glaucoma medications: For early primary open angle glaucoma and ocular hypertension (OHT) as first line treatment - 6 months study

Eligibility

Inclusion criteria

Inclusion criteria: Early primary open-angle glaucoma (POAG)-Not on any anti glaucoma medications Ocular Hypertension (=23 mmHg on 2 consecutive measurements)

Exclusion criteria

Exclusion criteria: Not willing to participate Patients with h/o prior intra ocular surgery except cataract surgery Moderate to advanced primary open angle glaucoma Congenital, childhood glaucomas Secondary glaucomas Patients with occludable/closed angles in gonioscopy Unable to use topical AGM With any contraindications for SLT

Design outcomes

Primary

Measure	Time frame
Decrease in intra ocular pressureTimepoint: 1 week and 1, 3, 6 months postoperatively	—

Secondary

Measure	Time frame
Reduce progression in visual field defectsTimepoint: 3 and 6 months postoperatively	—

Countries

India

Contacts

Public ContactDr Asha M S

Nethradhama Super Speciality Eye Hospital

drashamag@yahoo.co.uk9845373709

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026